M. Belhakim, L. Laklalech, Z. Asmae, M. Bouziane, M. Haboub, S. Arous, G. Bennouna, A. Drighil, R. Habbal
{"title":"Epidemiological and clinical insights into heart failure among the elderly: Implications for management","authors":"M. Belhakim, L. Laklalech, Z. Asmae, M. Bouziane, M. Haboub, S. Arous, G. Bennouna, A. Drighil, R. Habbal","doi":"10.1016/j.acvd.2024.10.047","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Heart failure (HF) presents a significant healthcare challenge in the elderly population.</div></div><div><h3>Objective</h3><div>This study aimed to describe the epidemiological, clinical, and therapeutic profile of elderly individuals with HF within our hospital structure.</div></div><div><h3>Method</h3><div>A transversal retrospective study conducted over an 18 year period (2006–2023) included all patients aged over 65 with HF, followed up in the therapeutic unit for heart failure in the cardiology department of our university hospital. Data were collected using Excel.</div></div><div><h3>Results</h3><div>Among the 3990 patients monitored for HF, 1902 were aged over 65 years (47.6%), predominantly men (64.3%), with a mean age of 75.4 yo (66–104). Prevalent cardiovascular risk factors included hypertension (37.2%), diabetes mellitus (30%), dyslipidemia (10%), and tobacco use (31.6%). Notable comorbidities included stroke (17%), chronic obstructive pulmonary disease (1.72%), and end-stage chronic kidney disease (10.3%). Ischemic heart disease (74.8%), dilated cardiomyopathy (11.4%), and valvular heart disease (4.3%) were the principal etiologies of HF. Dyspnea predominated, mainly categorized as New York Heart Association (NYHA) stage II. Atrial fibrillation was present in 11.3% of patients. The distribution of HF types included HFrEF (62.2%), HFpEF (11.9%), and HFmrEF (25.9%). Adherence to pharmacotherapy varied, with most patients adhering to beta-blockers (83.5%), angiotensin-converting enzyme inhibitors (ACE-I) (93.6%), and furosemide (86.2%). The hospitalization rate for acute decompensated HF was 49.2%, with an overall mortality rate of 11.2%.</div></div><div><h3>Conclusion</h3><div>In conclusion, this study outlines HF characteristics in elderly patients, emphasizing high prevalence of risk factors and comorbidities, predominant ischemic etiology, and challenges in management despite pharmacotherapy adherence. Integration of multidisciplinary approaches and tailored interventions may enhance outcomes in this vulnerable population.</div></div>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":"118 1","pages":"Pages S46-S47"},"PeriodicalIF":2.3000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1875213624003929","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Heart failure (HF) presents a significant healthcare challenge in the elderly population.
Objective
This study aimed to describe the epidemiological, clinical, and therapeutic profile of elderly individuals with HF within our hospital structure.
Method
A transversal retrospective study conducted over an 18 year period (2006–2023) included all patients aged over 65 with HF, followed up in the therapeutic unit for heart failure in the cardiology department of our university hospital. Data were collected using Excel.
Results
Among the 3990 patients monitored for HF, 1902 were aged over 65 years (47.6%), predominantly men (64.3%), with a mean age of 75.4 yo (66–104). Prevalent cardiovascular risk factors included hypertension (37.2%), diabetes mellitus (30%), dyslipidemia (10%), and tobacco use (31.6%). Notable comorbidities included stroke (17%), chronic obstructive pulmonary disease (1.72%), and end-stage chronic kidney disease (10.3%). Ischemic heart disease (74.8%), dilated cardiomyopathy (11.4%), and valvular heart disease (4.3%) were the principal etiologies of HF. Dyspnea predominated, mainly categorized as New York Heart Association (NYHA) stage II. Atrial fibrillation was present in 11.3% of patients. The distribution of HF types included HFrEF (62.2%), HFpEF (11.9%), and HFmrEF (25.9%). Adherence to pharmacotherapy varied, with most patients adhering to beta-blockers (83.5%), angiotensin-converting enzyme inhibitors (ACE-I) (93.6%), and furosemide (86.2%). The hospitalization rate for acute decompensated HF was 49.2%, with an overall mortality rate of 11.2%.
Conclusion
In conclusion, this study outlines HF characteristics in elderly patients, emphasizing high prevalence of risk factors and comorbidities, predominant ischemic etiology, and challenges in management despite pharmacotherapy adherence. Integration of multidisciplinary approaches and tailored interventions may enhance outcomes in this vulnerable population.
期刊介绍:
The Journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles and editorials. Topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.